Type 2 Diabetes Mellitus With Diabetic Nephropathy
Metabolic·MeSH: Diabetes Mellitus, Type 2
Prevalence
10700.0 / 100K
Incidence
600.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| GKT137831 | Calliditas Therapeutics AB (CALT) |
Frequently asked questions
How many drugs are in development for Type 2 Diabetes Mellitus With Diabetic Nephropathy?
BioSniper tracks 1 drug in development for Type 2 Diabetes Mellitus With Diabetic Nephropathy across 1 company.
How many clinical trials target Type 2 Diabetes Mellitus With Diabetic Nephropathy?
There are 1 clinical trial targeting Type 2 Diabetes Mellitus With Diabetic Nephropathy tracked by BioSniper.
What is the prevalence of Type 2 Diabetes Mellitus With Diabetic Nephropathy?
The estimated prevalence of Type 2 Diabetes Mellitus With Diabetic Nephropathy is approximately 10700.0 per 100,000 population.
Deep-dive into Type 2 Diabetes Mellitus With Diabetic Nephropathy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis